🔎 Trials Near Me

Domov › Mikrocitni rak pljuč › New Jersey

Klinične študije za Mikrocitni rak pljuč v New Jersey

17 študij za Mikrocitni rak pljuč išče udeležence na lokacijah v New Jersey.

Mesta v New Jersey

Uradno besedilo študije (angleško)

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • John Theurer Cancer Center at Hackensack UMC, Hackensack
Vključevanje udeležencevFaza 1
Starost 19 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06586957

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

  • MSK Basking Ridge, Basking Ridge
  • MSK Monmouth, Middletown
  • MSK Bergen., Montvale
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07476287

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • Inspira Medical Center Mullica Hill /ID# 280574, Mullica Hill
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07365241

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  • United Theranostics, Princeton
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07278479

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute of New Jersey, New Brunswick
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07488676

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  • Astera Cancer Care, East Brunswick
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07625644

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 1103), Hackensack
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06780137

A Study of Armored CAR T Cells in People With Cancer

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07783477

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute, New Brunswick
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07057791

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  • Regional Cancer Care Associates, Belleville
  • John Theurer Cancer Center at Hackensack UMC, Hackensack
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT06892548

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

  • Hackensack University Medical Center, Hackensack
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07488923

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT06807632

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Astera Cancer Care, East Brunswick
  • Hackensack Meridian Health Jsumc, Neptune City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06203210

A Study of LY4175408 in Participants With Advanced Cancer

  • John Theurer Cancer Center At Hackensack UMC, Hackensack
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923

A Study of Hospital-at-Home for People Receiving Tarlatamab

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 12. jun. 2026 · NCT06957314

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

  • Memorial Sloan Kettering at Basking Ridge, Basking Ridge
  • Memorial Sloan Kettering Monmouth, Middletown
  • Memorial Sloan Kettering Bergen, Montvale
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT05419076

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Englewood Hospital and Medical Center (site 202), Englewood
  • Summit Medical Group (site 205), Florham Park
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown
Vključevanje udeležencevFaza 1/2
Starost 18–80 · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT03556228

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.